Effective adjuvant chemotherapy for advanced nasopharyngeal carcinoma in children: a final update of a long-term prospective study in a single institution

Journal of Pediatric Hematology/oncology
T T GhimC S Alvarado

Abstract

The purpose of this study was to determine the efficacy and toxicity of a doxorubicin/cyclophosphamide-based chemotherapy and local radiation therapy in children with locally advanced or metastatic nasopharyngeal carcinoma (NPC). Twelve patients aged 6 to 20 years old were treated with a chemotherapy regimen comprised of vincristine (1.5 mg/m2) and doxorubicin (45 mg/m2) on day 1 and cyclophosphamide (210 mg/m2) and 5-fluorouracil (240 mg/m2) on days 1 to 5. Chemotherapy was administered every 3 weeks for 1 to 2 years. Radiotherapy to the primary site (59 to 68 Gy) and to the neck (59 to 66 Gy) was given before or after 2 to 4 courses of chemotherapy. All patients achieved a complete response 4 to 16 months from the start of therapy (median 7 months). Nine patients have remained tumor free from 2 to 21 years (median 11 years) from diagnosis. One child was lost to follow-up and one died of tuberculosis; both were disease-free. One child developed a secondary osteosarcoma in the left mandible. Chemotherapy caused grade 4 neutropenia and thrombocytopenia in four patients. There were no therapy-related deaths and the most common late effect of therapy was neck fibrosis, which was observed in all patients. We conclude that the chemo...Continue Reading

References

Jun 1, 1976·Cancer·C H FernandezR Rivera
Oct 1, 1990·International Journal of Radiation Oncology, Biology, Physics·L IngersollL J Peters
Aug 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M al-SarrafP J Ager
Mar 1, 1986·Head & Neck Surgery·B VikramS Manolatos
Jan 1, 1986·Pediatric Hematology and Oncology·H P RoperR H Campbell
Mar 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M GaspariniF Morandi
Dec 1, 1985·International Journal of Radiation Oncology, Biology, Physics·P R SchabingerV Saxena
Oct 15, 1995·International Journal of Radiation Oncology, Biology, Physics·A T ChanP J Johnson
Jun 1, 1995·Journal of Chemotherapy·Z D Barjaktarevic, I V Golubicic
May 1, 1995·Current Opinion in Oncology·A Fandi, E Cvitkovic
May 1, 1996·Medical and Pediatric Oncology·M Werner-WasikJ Goldwein
Dec 1, 1996·International Journal of Radiation Oncology, Biology, Physics·J C LinC Y Hsu

❮ Previous
Next ❯

Citations

Feb 13, 2001·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·O UzelS Okkan
Dec 31, 2003·International Journal of Radiation Oncology, Biology, Physics·Siddhartha LaskarKetayun A Dinshaw
Mar 8, 2000·International Journal of Radiation Oncology, Biology, Physics·S L WoldenN Wollner
Jan 9, 2003·The Lancet Oncology·Inci AyanNihat Ayan
Oct 12, 2005·Journal of Pediatric Hematology/oncology·Motti HaimiAbraham Kuten
Apr 27, 2004·Cancer·Stephen T SonisUNKNOWN International Society for Oral Oncology
Jun 1, 2006·The Laryngoscope·Trinitia CannonMark C Weissler
Jul 19, 2015·Journal of the Egyptian National Cancer Institute·Ehab M Khalil, Manal M Anwar
Mar 15, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A FandiE Cvitkovic
Aug 26, 2010·Cancer·Daniel Ka Leung CheukCarlos Rodriguez-Galindo
Jun 18, 2014·American Journal of Clinical Oncology·Julie C GreenwaltWilliam M Mendenhall
Jan 22, 2000·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S SahraouiA Kahlain

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved